Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease

Recruiting

Phase 2

RuxolitinibRuxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease

Sponsor:

University of Pennsylvania

Code:

NCT07085039

Conditions

Castleman's Disease (CD)

Idiopathic Multicentric Castleman's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ruxolitinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-06. This information was provided to ClinicalTrials.gov by University of Pennsylvania on 2025-10-10.